Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts
Class II · Moderate risk Terminated Initiated Mar 25, 2016 (11 years ago)

All nifedipine Products

Class II — Moderate risk. May cause temporary or reversible harm; serious harm unlikely.

Why it was recalled

Lack of Processing Controls

Cause type: cGMP deviation

Departures from current Good Manufacturing Practice found in production or during FDA inspection. A broad quality-system cause: the batch was made under conditions that fall short of FDA manufacturing standards. All cgmp deviation recalls.

What was recalled

All nifedipine Products, Rx Only, Compounded by RELIABLE DRUG/RELIABLE COMPOUNDING PHARMACY, 801 Irving St., SAN FRANCISCO, CA 94122.

Drug: Nifedipine Category: Blood Pressure Medication

Recalling firm
Reliable Rexall-A Compounding Pharmacy
Origin
CA, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-1100-2016 · FDA notice

Check, then ask. Class II means harm is possible but usually temporary or reversible. Find the lot number on your package; if it matches, ask your pharmacist about a replacement. Do not simply stop a prescribed medication on your own - the gap can be riskier than the recall. This recall is now terminated, which means the firm has finished removing the affected product; anything on pharmacy shelves today should be unaffected.

Other Nifedipine recalls

See all
Class II · Moderate risk

Nifedipine USP for prescription compounding

CGMP Deviations: Lack of stability data and controls to support the manufacturers assigned retest or expiration date in firm's container/closure system.

Terminated Stability / shelf life American Pharmaceutical Ingredients LLC NDC 58597-8025-2 D-0513-2018
Class III · Low risk

Adalat CC (nifedipine)

Cross Contamination with another product:residual powder found in inlet air duct identified as sorafenib

Terminated Cross-contamination Alvogen, Inc D-0635-2017
Class III · Low risk

Adalat CC (nifedipine)

Cross Contamination with another product:residual powder found in inlet air duct identified as sorafenib

Terminated Cross-contamination Alvogen, Inc D-0634-2017

Other recalls by Reliable Rexall-A Compounding Pharmacy

All 2016 recalls
Class II · Moderate risk

All Malarone

Lack of Processing Controls

Terminated cGMP deviation Reliable Rexall-A Compounding Pharmacy D-1136-2016